UY31609A1 - "(-) ácido 2-[1-(7-metil-2-(morfolin-4-il) 4-oxo-4h-pirido[1,2-a]pirimidin-9-il)etilamino]benzoico enantioméricamente puro, su uso en terapia médica, y una composición farmacéutica que lo comprende-026." - Google Patents
"(-) ácido 2-[1-(7-metil-2-(morfolin-4-il) 4-oxo-4h-pirido[1,2-a]pirimidin-9-il)etilamino]benzoico enantioméricamente puro, su uso en terapia médica, y una composición farmacéutica que lo comprende-026."Info
- Publication number
- UY31609A1 UY31609A1 UY031609A UY31609A UY31609A1 UY 31609 A1 UY31609 A1 UY 31609A1 UY 031609 A UY031609 A UY 031609A UY 31609 A UY31609 A UY 31609A UY 31609 A1 UY31609 A1 UY 31609A1
- Authority
- UY
- Uruguay
- Prior art keywords
- pyrimidin
- oxo
- methyl
- pharmaceutical composition
- enantiomerically pure
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 238000013160 medical therapy Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 title 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000003906 phosphoinositides Chemical class 0.000 abstract 2
- -1 7-methyl-2- (morpholin-4-yl) -4-oxo-4H-pyrido [1,2-a] pyrimidin-9-yl Chemical group 0.000 abstract 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a (-) ácido 2-[1-(7-metil-2-(morfolin-4-il)-4-oxo-4H-pirido[1,2-a]pirimidin-9-il)etilamino]benzoico enantioméricamente puro o sales farmacéuticamente aceptables del mismo, encontrándose en un estado sólido, su uso en terapia médica, una composición farmacéutica que lo comprende, su uso en la preparación de un medicamento para uso en un método para prevenir o tratar enfermedades, y su uso en un método para prevenir o tratar la enfermedad. La presente invención se refiere a un inhibidor selectivo de fosfoinositida (PI) 3-quinas B(Beta) y el uso del inhibidor selectivo en p. ej. terapia antitrombótica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2349808P | 2008-01-25 | 2008-01-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY31609A1 true UY31609A1 (es) | 2009-08-31 |
Family
ID=40899463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY031609A UY31609A1 (es) | 2008-01-25 | 2009-01-23 | "(-) ácido 2-[1-(7-metil-2-(morfolin-4-il) 4-oxo-4h-pirido[1,2-a]pirimidin-9-il)etilamino]benzoico enantioméricamente puro, su uso en terapia médica, y una composición farmacéutica que lo comprende-026." |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20090191177A1 (es) |
| EP (1) | EP2245030A4 (es) |
| JP (1) | JP2011510071A (es) |
| KR (1) | KR20100118977A (es) |
| CN (1) | CN101925601A (es) |
| AR (1) | AR070236A1 (es) |
| AU (1) | AU2009206804A1 (es) |
| BR (1) | BRPI0906805A2 (es) |
| CA (1) | CA2712022A1 (es) |
| CL (1) | CL2009000148A1 (es) |
| MX (1) | MX2010008097A (es) |
| PE (1) | PE20091402A1 (es) |
| RU (1) | RU2010133715A (es) |
| TW (1) | TW200936138A (es) |
| UY (1) | UY31609A1 (es) |
| WO (1) | WO2009093972A1 (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI378933B (en) | 2008-10-14 | 2012-12-11 | Daiichi Sankyo Co Ltd | Morpholinopurine derivatives |
| FR2969613B1 (fr) * | 2010-12-23 | 2013-02-08 | Sanofi Aventis | Nouveaux derives de 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one, leur preparation et leur utilisation pharmaceutique |
| FR2969612B1 (fr) * | 2010-12-23 | 2013-02-08 | Sanofi Aventis | Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one, leur preparation et leur utilisation pharmaceutique |
| HUE024504T2 (en) | 2010-12-23 | 2016-01-28 | Sanofi Sa | Pyrimidine derivatives, a process for their preparation and their use in medicine |
| CN104592222B (zh) * | 2014-12-26 | 2016-08-24 | 苏州明锐医药科技有限公司 | 抗血小板药物azd6482的制备方法 |
| TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| EP4149477A4 (en) * | 2020-05-14 | 2024-04-03 | The Heart Research Institute Ltd | TREATMENT OF THROMBOSIS AND RELATED DISEASES WITH AN ANTI-PLATELET AGENT |
| BR112023022940A2 (pt) | 2021-05-03 | 2024-01-23 | Petra Pharma Corp | Inibidores alostéricos de cromenona de fosfoinositídeo 3-quinase (pi3k) para o tratamento de doenças |
| IL308776A (en) | 2021-05-27 | 2024-01-01 | Petra Pharma Corp | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of cancer |
| TW202329930A (zh) | 2021-09-30 | 2023-08-01 | 美商佩特拉製藥公司 | 用於治療疾病之磷酸肌醇3-激酶(pi3k)之異位色烯酮抑制劑 |
| WO2023060262A1 (en) * | 2021-10-07 | 2023-04-13 | Relay Therapeutics, Inc. | Pi3k-alpha inhibitors and methods of use thereof |
| WO2023081209A1 (en) * | 2021-11-03 | 2023-05-11 | Zeno Management, Inc. | Pi3k inhibitors and methods of treating cancer |
| WO2023159155A1 (en) * | 2022-02-18 | 2023-08-24 | Pivalent Therapeutics, Inc. | Inhibitors of phosphoinositide 3-kinase (pi3k) and uses thereof |
| CN119095846A (zh) * | 2022-04-24 | 2024-12-06 | 益方生物科技(上海)股份有限公司 | 化合物、其制备方法和用途 |
| WO2024051778A1 (en) * | 2022-09-09 | 2024-03-14 | InventisBio Co., Ltd. | Compounds, preparation methods and uses thereof |
| WO2024081889A1 (en) * | 2022-10-14 | 2024-04-18 | Genesis Therapeutics, Inc. | 4h-pyrido[1,2-a]pyrimidin-4-one derivatives for treating cancer |
| WO2024099437A1 (en) * | 2022-11-11 | 2024-05-16 | Fochon Biosciences, Ltd. | Compounds as protein kinase inhibitors |
| WO2024151759A1 (en) * | 2023-01-11 | 2024-07-18 | Synnovation Therapeutics, Inc. | HETEROCYCLIC COMPOUNDS AS PI3Kα INHIBITORS |
| WO2024259491A1 (en) * | 2023-06-23 | 2024-12-26 | The Heart Research Institute Ltd | New synthesis method |
| WO2026013052A1 (en) * | 2024-07-09 | 2026-01-15 | Institut National de la Santé et de la Recherche Médicale | Methods of treating familial adenomatous polyposis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2106783T3 (es) * | 1990-06-20 | 1997-11-16 | Upjohn Co | 1-benzopiran-4-onas y 2-amino-1,3-benzoxacin-4-onas antiarterosclerosis y antitromboticas. |
| AU3042601A (en) * | 2000-01-24 | 2001-07-31 | Thrombogenix Pty Ltd | Therapeutic morpholino-substituted compounds |
| CA2495661C (en) * | 2002-08-16 | 2011-06-14 | Kinacia Pty Ltd. | Inhibition of phosphoinositide 3-kinase beta |
-
2009
- 2009-01-22 KR KR1020107017149A patent/KR20100118977A/ko not_active Withdrawn
- 2009-01-22 RU RU2010133715/04A patent/RU2010133715A/ru not_active Application Discontinuation
- 2009-01-22 JP JP2010544271A patent/JP2011510071A/ja active Pending
- 2009-01-22 AU AU2009206804A patent/AU2009206804A1/en not_active Abandoned
- 2009-01-22 BR BRPI0906805-8A patent/BRPI0906805A2/pt not_active IP Right Cessation
- 2009-01-22 WO PCT/SE2009/050065 patent/WO2009093972A1/en not_active Ceased
- 2009-01-22 EP EP09703707A patent/EP2245030A4/en not_active Withdrawn
- 2009-01-22 CA CA2712022A patent/CA2712022A1/en not_active Abandoned
- 2009-01-22 MX MX2010008097A patent/MX2010008097A/es not_active Application Discontinuation
- 2009-01-22 CN CN2009801035429A patent/CN101925601A/zh active Pending
- 2009-01-23 AR ARP090100205A patent/AR070236A1/es unknown
- 2009-01-23 CL CL2009000148A patent/CL2009000148A1/es unknown
- 2009-01-23 PE PE2009000099A patent/PE20091402A1/es not_active Application Discontinuation
- 2009-01-23 UY UY031609A patent/UY31609A1/es unknown
- 2009-01-23 TW TW098103073A patent/TW200936138A/zh unknown
- 2009-01-25 US US12/359,323 patent/US20090191177A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009093972A1 (en) | 2009-07-30 |
| AR070236A1 (es) | 2010-03-25 |
| TW200936138A (en) | 2009-09-01 |
| PE20091402A1 (es) | 2009-10-21 |
| US20090191177A1 (en) | 2009-07-30 |
| KR20100118977A (ko) | 2010-11-08 |
| EP2245030A1 (en) | 2010-11-03 |
| MX2010008097A (es) | 2010-08-04 |
| BRPI0906805A2 (pt) | 2015-07-14 |
| CN101925601A (zh) | 2010-12-22 |
| CA2712022A1 (en) | 2009-01-30 |
| EP2245030A4 (en) | 2012-03-21 |
| JP2011510071A (ja) | 2011-03-31 |
| AU2009206804A1 (en) | 2009-07-30 |
| RU2010133715A (ru) | 2012-02-27 |
| CL2009000148A1 (es) | 2010-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY31609A1 (es) | "(-) ácido 2-[1-(7-metil-2-(morfolin-4-il) 4-oxo-4h-pirido[1,2-a]pirimidin-9-il)etilamino]benzoico enantioméricamente puro, su uso en terapia médica, y una composición farmacéutica que lo comprende-026." | |
| UY39786A (es) | Derivados de Triazolopirimidina y su uso en el Tratamiento de Enfermedades | |
| HN2008001666A (es) | Derivados acidos de cicloalquilamino | |
| SV2011003939A (es) | Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades | |
| GT200500325A (es) | Pirazolo-pirimidinas 1,4-sustituidas como inhibidores de quinasa | |
| GT200800256A (es) | Derivados de pirazolo [3,4-d]-pirimidina útiles para tratar trastornos respiratorios | |
| SV2009003293A (es) | Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona, procedimiento para su preparacion y su uso como agentes farmaceuticos | |
| ECSP109934A (es) | Compuesto - 946 | |
| AR091876A1 (es) | Combinaciones farmaceuticas para el tratamiento de enfermedades proliferativas | |
| EA200802208A1 (ru) | Применение флибансерина для лечения расстройств полового влечения в постклимактерический период | |
| CO6220962A2 (es) | Usos terapeuticos novedosos de 1-[2(2,4-dimetilfenilsulfanil)fenil]-piperazina | |
| AR060019A1 (es) | Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo | |
| PA8622401A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico,procesos para su preparacion y su uso como medicamentos | |
| AR069508A1 (es) | Derivados de quinolina 057; un proceso para su preparacion; una composicion farmaceutica; la preparacion de esta y el uso del compuesto para preparar un medicamento | |
| CO2021000450A2 (es) | Forma de dosificación farmacéutica administrable por vía oral con liberación modificada | |
| PA8596801A1 (es) | Derivados de acido acetico sustituido con cicloalquilmetoxi, procedimientos para su preparacion y su uso como farmacos | |
| DOP2005000051A (es) | Oxadiazolonas, procedimientos para su preparacion y su uso como productos farmaceuticos | |
| CR11823A (es) | Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenarativas e inflamatorias | |
| AR117614A1 (es) | Forma de dosificación farmacéutica administrable por vía oral con liberación modificada | |
| UY29065A1 (es) | Derivados del ácido alcanoico arilcicloalquil-sustituidos, procedimientos para su preparación y su uso como productos farmacéuticos. | |
| CO6592037A2 (es) | Combinación de un aine y un aminoacido | |
| AR052641A1 (es) | Uso de acido docosahexaenoico (dha) y acido araquidonico (ara) para la manufactura de un medicamento para la prevencion o tratamiento de infecciones respiratorias en infantes | |
| ECSP066836A (es) | Piperazinas derivadas de úrea para el tratamiento de la endometrosis | |
| AR061046A1 (es) | Mirtazapina para el tratamiento del dolor neuropatico | |
| PA8596601A1 (es) | Derivados cicloalquilo que tienen grupos acido carboxilico bioisostericos, procesos para su preparacion y su uso como composiciones farmaceuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DESI | Application deemed to be withdrawn |
Effective date: 20121217 |